Latest Fiji News

The FDA’s recent ruling classifying traditionally prepared kava beverages as food under U.S. law clears a major regulatory hurdle for The Calmer Co, accelerating its growth on Amazon and strengthening its U.S. expansion strategy.

Dome Gold Mines Ltd is launching a $7 million convertible note offering aimed at funding key developments in its Fiji mining projects, including the Sigatoka feasibility study and exploration programs.

Alice Queen Limited has reported significant progress at its Viani Fiji Project, extending high-grade gold mineralisation over a 5km strike. The company also registered a mining lease application for its Horn Island Project and raised $1 million via convertible notes to fund ongoing exploration.

Dome Gold Mines reports steady progress on its Sigatoka heavy mineral sands project despite delays in a government-led river desilting program, while exploring funding options for its Nadrau copper-gold project in Fiji.

Firebrick Pharma is set to expand its Nasodine product line with the launch of a new throat spray, targeting export markets starting November 2025, beginning with Singapore.

Streamplay Studio Limited reports its second consecutive cash-flow positive quarter, driven by strong game launches and platform growth across Tier 1 markets and emerging regions.

Alice Queen Limited (ASX – AQX) is set to raise $1 million through a two-tranche share placement accompanied by free-attaching options, alongside a bonus loyalty option offer to existing shareholders.

The Calmer Co International Limited has reported its strongest quarterly revenue ever at $2.4 million, driven by robust Australian retail sales and expanding US market presence. The company is also advancing a $1.4 million convertible note to fuel growth and inventory expansion.

The Calmer Co. has secured $700,000 in the first tranche of a $1.4 million convertible note raise, welcoming US distributor Applied Food Sciences as a strategic investor to fuel its expanding wholesale presence.

Dome Gold Mines has successfully closed its Share Purchase Plan, raising $366,000 to support ongoing exploration and development in Fiji. The company is advancing key projects including the Sigatoka mineral sands and Ono Island gold ventures.

Firebrick Pharma reported a substantial increase in Nasodine Nasal Spray revenues in FY25, alongside a widening net loss driven by reduced R&D incentives and increased marketing investments. The company is advancing its international rollout with new licensing deals and board appointments.

Dome Gold Mines Ltd invites eligible shareholders to participate in a $5 million Share Purchase Plan at $0.15 per share, aiming to fund the transition to production at its Sigatoka Sands Project and exploration of other Fijian assets.